Sijun Pan

Sijun Pan

Auto-generated profile, based on publicly available information

Sijun Pan

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543, Singapore.

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2014 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ZLZhengqiu Li
Zhengqiu Li
DWDanyang Wang
Danyang Wang
LLLin Li
Lin Li
SPSijun Pan
Sijun Pan
ZNZhenkun Na
Zhenkun Na
SYShao Q. Yao
Shao Q. Yao

18 November 2015 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
SPSijun Pan
Sijun Pan
HZHailong Zhang
Hailong Zhang
CWChenyu Wang
Chenyu Wang
SYSamantha C. L. Yao
Samantha C. L. Yao
SYShao Q. Yao
Shao Q. Yao
Direct capture of drug–target complexesin situby using affinity-based probes allows target identification of natural products and bioactive compounds, even if the binding is reversible with moderate affinity.

8 March 2021 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
SPSijun Pan
Sijun Pan
YZYan Zhang
Yan Zhang
ANAuginia Natalia
Auginia Natalia
CLCarine Z. J. Lim
Carine Z. J. Lim
NHNicholas R. Y. Ho
Nicholas R. Y. Ho
HSHuilin Shao
Huilin Shao

22 November 2016 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YXYusheng Xie
Yusheng Xie
JGJingyan Ge
Jingyan Ge
HLHaipeng Lei
Haipeng Lei
Bo PengBo Peng
Bo Peng
HZHuatang Zhang
Huatang Zhang
HSHongyan Sun
Hongyan Sun

7 August 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SPSijun Pan
Sijun Pan
SJSe‐Young Jang
Se‐Young Jang
DWDanyang Wang
Danyang Wang
SLSi Si Liew
Si Si Liew
ZLZhengqiu Li
Zhengqiu Li
SYShao Q. Yao
Shao Q. Yao

1 August 2023 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
SPSijun Pan
Sijun Pan
ADAixiang Ding
Aixiang Ding
YLYisi Li
Yisi Li
YSYaxin Sun
Yaxin Sun
YZYueqin Zhan
Yueqin Zhan
HSHuilin Shao
Huilin Shao
Over the past decade, remarkable advances have been witnessed in the development of small-molecule probes. These molecular tools have been widely applied for interrogating proteins, pathways and drug–target interactions in preclinical research. While novel structures and designs are commonly explored in probe development, the clinical translation of small-molecule probes remains limited, primarily due to safety and regulatory considerations. Recent synergistic developments – interfacing novel chemical probes with complementary analytical technologies – have introduced and expedited diverse biomedical opportunities to molecularly characterize targeted drug interactions directly in the human body or through accessible clinical specimens (e.g., blood and ascites fluid). These integrated developments thus offer unprecedented opportunities for drug development, disease diagnostics and treatment monitoring. In this review, we discuss recent advances in the structure and design of small-molecule probes with novel functionalities and the integrated development with imaging, proteomics and other emerging technologies. We further highlight recent applications of integrated small-molecule technologies for the molecular analysis of drug–target interactions, including translational applications and emerging opportunities for whole-body imaging, tissue-based measurement and blood-based analysis.